a biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms.
Industry Biotechnology
A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with ACIU. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then ACIU could also see price increases.
Ticker / NAME | Correlation To BDTX | 1D Price Change % | ||
---|---|---|---|---|
BDTX | 100% | -4.71% | ||
ACIU - BDTX | 54% Loosely correlated | -0.92% | ||
ABOS - BDTX | 37% Loosely correlated | -0.84% | ||
AVIR - BDTX | 34% Loosely correlated | +0.64% | ||
MDGL - BDTX | 34% Loosely correlated | +0.93% | ||
ZYME - BDTX | 33% Loosely correlated | -1.49% | ||
More |